Hydrochlorothiazide

Product NDC
70518-3002
11-digit product format
705183002
Labeler code
70518
Product ID
70518-3002_ba4ae529-f0ed-34c5-e053-2995a90ac946
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA040412
Marketing category
ANDA
Marketing start
2021-01-29
Marketing end
0000-00-00
Substance
HYDROCHLOROTHIAZIDE
Active strength
25 mg/1
Pharmacologic classes
Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3002-02023-03-14C16284748780-1f386c649-9ffe-0266-e053-dadaa90a7c1a7dbe6964-aa5a-4d02-8230-e1113c9fe2f5
70518-3002-02023-01-30C16284748780-1f386c649-9ffe-0266-e053-dadaa90a7c1a7dbe6964-aa5a-4d02-8230-e1113c9fe2f5

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3002-070518300200100 POUCH in 1 BOX (70518-3002-0) > 1 TABLET in 1 POUCH (70518-3002-1) 100 pouch2021-01-290000-00-00NoNoCurrent